ARCHIVES

Cell Therapeutics To Appeal FDA Decision on Pixantrone.

This article is from The Cancer Letter archive.

Vol. 36 No. 33 | September 17, 2010

Download PDF Visit The Full Archive

Related Articles

City of Hope Selects Michael Friedman As President, CEO

May 16, 2003

News Analysis: Filing Will Ignite Complex Litigation Costing Millions, With Uncertain Rewards

March 9, 2012

Bertagnolli: Why Brigham Stopped Making Morcellation Available Outside Of A Registry Trial

July 4, 2014

Bush Proposes $2.8 Billion Increase For NIH In FY2002, Vows $4.1B Next Year.

March 2, 2001

Clinical Trials: NCI Puts State of Science Meetings on the Web

May 12, 2000

LAK/IL-2 Extramural Trials Expanded to 20 More cancers

January 8, 1988